drug · unknown
BB-1701
Phase 2updated 3mo agoby Bliss Biopharmaceutical (Hangzhou) Co Ltd🔗 ChEMBL
Phase 2community read0 votes
Unknown drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying BB-1701
- phase2A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer
- phase1A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that